X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
1. 3,4 Diaminopyridine
2. 3,4-diaminopyridine
3. Amifampridine
4. Firdapse
5. Ruzurgi
1. Zenas
2. 3,4-diaminopyridine Phosphate
3. 446254-47-3
4. Firdapse (tn)
5. Amifampridine Phosphate [mi]
6. 3,4-pyridinediamine, Phosphate (1:1)
7. Amifampridine Phosphate [usan]
8. Amifampridine Phosphate [mart.]
9. Amifampridine Phosphate [who-dd]
10. 446254-47-3 (phosphate)
11. Amifampridine (phosphate)
12. Amifampridine Phosphate [ema Epar]
13. 3,4-dapp
14. 8hf8fin815
15. Pyridine-3,4-diamine Phosphate
16. Amifampridine Phosphate (usan)
17. Unii-8hf8fin815
18. Phosphoric Acid;pyridine-3,4-diamine
19. Starbld0005260
20. Schembl3958357
21. Chembl3301611
22. Dtxsid40196254
23. Hy-14946a
24. Amifampridine Phosphate [orange Book]
25. Cs-0009524
26. 3,4-diaminopyridin-1-ium Dihydrogen Phosphate
27. D10689
28. Q27270515
| Molecular Weight | 207.12 g/mol |
|---|---|
| Molecular Formula | C5H10N3O4P |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 0 |
| Exact Mass | 207.04089281 g/mol |
| Monoisotopic Mass | 207.04089281 g/mol |
| Topological Polar Surface Area | 143 Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 124 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Neuromuscular Agents
Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (NEUROMUSCULAR BLOCKING AGENTS), and drugs that act centrally as skeletal muscle relaxants (MUSCLE RELAXANTS, CENTRAL). Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS. (See all compounds classified as Neuromuscular Agents.)
Potassium Channel Blockers
A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS. (See all compounds classified as Potassium Channel Blockers.)
Market Place
